Ardelyx reported $120.88M in Sales Revenues for its fiscal quarter ending in June of 2026.





Sales Change Date
Abbott USD 13.01B 423M Sep/2026
Amgen USD 10.4B 300M Sep/2026
Ardelyx USD 120.88M 26.41M Jun/2026
aTyr Pharma USD 2.44M 151K Jun/2026
Corcept Therapeutics USD 340.5M 84.35M Sep/2026
Curis USD 1.14M 1.41M Dec/2025
Sanofi EUR 12.3B 160M Jun/2026
TG Therapeutics USD 259.94M 19.6M Sep/2026
United Therapeutics USD 832.5M 49.2M Sep/2026